BridgeMD
New treatment option for ALS (Amyotrophic Lateral Sclerosis)
Official title Augmented Reality BCI Longitudinal Study for Persons With Late Stage ALS
ClinicalTrials.gov ID: NCT06810219
What this study is testing
- What it's testing
- The goal of this study is refine the usability of a BCI based communication platform. The study will take place in the greater Los Angeles area and will enroll up to 10 participants with late stage ALS.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Must have someone (LAR) who can consent to their participation and who will be present in the study alongside the participant
- Must have a designated individual who can be trained on the Cognixion system
- Fluent in understanding English
- 18 years or older
- Must have ALS and need an assistive communication device
You likely can't join if
- Disruption in English comprehension, either due to lack of fluent proficiency or due to a developmental/acquired language disorder (e.g. aphasia)
- Severely hearing impaired or deaf
- Sensitivity to flashing lights
- History of epilepsy and/or seizures
- Vision disorders restricting the visual field such as glaucoma, diplopia (double vision), nystagmus (involuntary eye movements)
- History of vertigo or other vestibular disorders
See the full eligibility criteria
- Must have someone (LAR) who can consent to their participation and who will be present in the study alongside the participant
- Must have a designated individual who can be trained on the Cognixion system
- Fluent in understanding English
- 18 years or older
- Must have ALS and need an assistive communication device
- Must be able to engage in volitional eye opening and sustain eye opening independently for x duration
- Must have a way to communicate apart from using the Cognixion device such as vocalizations, head nod, eye blinks, eyebrow raises, etc. At a minimum, reliable way of communicating "Yes" and "No"
- Disruption in English comprehension, either due to lack of fluent proficiency or due to a developmental/acquired language disorder (e.g. aphasia)
- Severely hearing impaired or deaf
- Sensitivity to flashing lights
- History of epilepsy and/or seizures
- Vision disorders restricting the visual field such as glaucoma, diplopia (double vision), nystagmus (involuntary eye movements)
- History of vertigo or other vestibular disorders
- Scalp that is prone to irritation, inflammation, injury, or infectious process
The study team makes the final eligibility decision.
Where it's taking place
- Santa Barbara, California, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Santa Barbara, California, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.